Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zulresso
Zulresso
Sage braces for make-or-break depression data
BioPharma Dive
Tue, 05/4/21 - 10:41 pm
SAGE Therapeutics
earnings
major depressive disorder
Zulresso
Sage to lay off half of workforce in cost-cutting retrenchment
BioPharma Dive
Tue, 04/7/20 - 07:47 pm
SAGE Therapeutics
layoffs
depression
Zulresso
Sage's new drug starts slow, as Wall Street waits for depression data
Biopharma Dive
Wed, 11/13/19 - 11:25 pm
SAGE Therapeutics
postpartum depression
Zulresso
drug launches
Sage strategy for postpartum depression drug Zulresso keys on patient support
Fierce Pharma
Mon, 07/1/19 - 12:03 pm
SAGE Therapeutics
postpartum depression
patients
Zulresso
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
Xconomy
Tue, 03/19/19 - 08:27 pm
SAGE Therapeutics
postpartum depression
Zulresso
brexanolone
PDUFA Date for Postpartum Depression Drug Delayed Three months
CP Wire
Tue, 11/20/18 - 09:42 am
FDA
SAGE Therapeutics
postpartum depression
Zulresso
PDUFA Date for Postpartum Depression Drug Delayed Three months
Tue, 11/20/18 - 09:23 am
Zulresso
postpartum depression
SAGE Therapeutics
Sage depression drug to cost between $20K and $35K, if approved
Biopharma Dive
Wed, 11/7/18 - 07:12 pm
SAGE Therapeutics
Zulresso
postpartum depression
FDA
drug pricing